XML 38 R16.htm IDEA: XBRL DOCUMENT v3.8.0.1
(Deficit) Equity
12 Months Ended
Dec. 31, 2017
Equity [Abstract]  
(Deficit) Equity
(Deficit) Equity

Our capital accounts are comprised of a 2% general partner interests and 98% limited partner interests. The common units represent limited partner interests in us. The holders of common units, both public and SPLC, are entitled to participate in partnership distributions and have limited rights of ownership as provided for under our partnership agreement. Our general partner participates in our distributions and also currently holds IDR’s that entitle it to receive increasing percentages of the cash we distribute from operating surplus.

At-the-Market Program

On March 2, 2016, we commenced an “at-the-market” equity distribution program pursuant to which we may issue and sell common units for up to $300.0 million in gross proceeds. This program is registered with the SEC on an effective registration statement on Form S-3.

During the quarter ended September 30, 2017, we completed the sale of 5,200,000 common units under this program for $139.8 million net proceeds ($140.2 million gross proceeds, or an average price of $26.96 per common unit, less $0.4 million of transaction fees). In connection with the issuance of the common units, we issued 106,122 general partner units to our general partner for $2.9 million in order to maintain its 2% general partner interest in us. We used the net proceeds from these sales of common units and from our general partner’s proportionate capital contribution to repay borrowings outstanding under the Five Year Revolver due October 2019 and for general partnership purposes.

During the quarter ended June 30, 2017, we completed the sale of 94,925 common units under this program for $2.9 million net proceeds ($3.0 million gross proceeds, or an average price of $31.51 per common unit, less $0.1 million of transaction fees). In connection with the issuance of the common units, we issued 1,938 general partner units to our general partner for $0.1 million in order to maintain its 2% general partner interest in us. We used proceeds from these sales of common units and from our general partner's proportionate capital contribution for general partnership purposes.

During the quarter ended March 31, 2016, we completed the sale of 750,000 common units under this program for $25.4 million net proceeds ($25.5 million gross proceeds, or an average price of $34.00 per common unit, less $0.1 million of transaction fees). In connection with the issuance of the common units, we issued 15,307 general partner units to our general partner for $0.5 million in order to maintain its 2% general partner interest in us. We used the net proceeds from these sales of common units and from our general partner’s proportionate capital contribution to repay borrowings outstanding under the Five Year Revolver due October 2019 and the 364-Day Revolver and for general partnership purposes.

Other than as described above, we did not have any sales under this program.

Public Offerings

On September 15, 2017, we completed the sale of 5,170,000 common units in a registered public offering for proceeds of $135.1 million, or $26.14 per common unit. In connection with the issuance of common units, we issued 105,510 general partner units to our general partner for $2.8 million in order to maintain its 2% general partner interest in us. We used the net proceeds from these sales of common units and from our general partner’s proportionate capital contribution to repay borrowings outstanding under the Five Year Revolver due October 2019 and for general partnership purposes.

On May 23, 2016, in conjunction with the May 2016 Acquisition, we completed the sale of 10,500,000 common units in a registered public offering for $345.8 million net proceeds ($349.1 million gross proceeds, or $33.25 per common unit, less $2.9 million of underwriter's fees and $0.4 million of transaction fees). In connection with the issuance of common units, we issued 214,285 general partner units to our general partner as non-cash consideration of $7.1 million in order to maintain its 2% general partner interest in us. We used the net proceeds from the May 2016 Offering and from our general partner's proportionate capital contribution to partially fund the May 2016 Acquisition.

As part of the registered public offering on May 23, 2016, the underwriters received an option to purchase an additional 1,575,000 common units, which they exercised in full on June 9, 2016 for $51.8 million net proceeds ($52.4 million gross proceeds, or $33.25 per common unit, less $0.5 million in underwriter's fees and $0.1 million of transaction fees). In connection with the issuance of common units, we issued 32,143 general partner units to our general partner for $1.1 million in order to maintain its 2% general partner interest in us.

On March 29, 2016, we completed the sale of 12,650,000 common units in a registered public offering (the “March 2016 Offering”) for $395.1 million net proceeds ($401.6 million gross proceeds, or $31.75 per common unit, less $6.3 million of underwriter's fees and $0.2 million of transaction fees). In connection with the issuance of the common units, we issued 258,163 general partner units to our general partner for $8.2 million in order to maintain its 2% general partner interest in us. We used the net proceeds from the March 2016 Offering and from our general partner’s proportionate capital contribution to repay borrowings outstanding under the Five Year Revolver due October 2019 and the 364-Day Revolver and for general partnership purposes.

On November 17, 2015, we completed the sale of 9,200,000 common units representing limited partner interests to unaffiliated third parties in the Offering for approximately $296.8 million net proceeds ($299.4 million gross proceeds, less $2.6 million of underwriters’ discount and other offering costs). In connection with the issuance of the common units, we issued 187,755 general partner units to our general partner to maintain its 2% general partner interest in us.
 
Private Placement

On May 18, 2015, we completed the sale of 7,692,308 common units in the private placement (“Private Placement”) for $297.4 million net proceeds ($300.0 million gross proceeds, or $39.00 per common unit, less $2.6 million of placement agent fees). In connection with the issuance of the common units, we issued 156,986 general partner units to the general partner for $6.1 million in order to maintain its 2% general partner interest in us.
Units Outstanding
As of December 31, 2017, we had 187,782,369 common units outstanding, of which 98,832,233 were publicly owned. SPLC owned 88,950,136 common units representing an aggregate 46.4% limited partner interest in us, all of the IDR's, and 3,832,293 general partner units, representing a 2% general partner interest in us.
The changes in the number of units outstanding from December 31, 2016 through December 31, 2017 are as follows:
 
(in units)
Public
Common
 
SPLC
Common
 
SPLC Subordinated
 
General
Partner
 
Total
Balance as of December 31, 2015
62,892,308

 
21,475,068

 
67,475,068

 
3,098,825

 
154,941,269

Units issued in connection with ATM program
750,000

 

 

 
15,307

 
765,307

Units issued in connection with public offerings
24,725,000

 

 

 
504,591

 
25,229,591

Balance as of December 31, 2016
88,367,308

 
21,475,068

 
67,475,068

 
3,618,723

 
180,936,167

Expiration of subordination period

 
67,475,068

 
(67,475,068
)
 

 

Units issued in connection with ATM program
5,294,925

 

 

 
108,060

 
5,402,985

Units issued in connection with public offerings
5,170,000

 

 

 
105,510

 
5,275,510

Balance as of December 31, 2017
98,832,233

 
88,950,136

 

 
3,832,293

 
191,614,662



Expiration of Subordination Period
On February 15, 2017, all of the subordinated units converted into common units following the payment of the cash distribution for the fourth quarter of 2016. Each of our 67,475,068 outstanding subordinated units converted into one common unit. The converted units will participate pro rata with the other common units in distributions of available cash. The conversion of the subordinated units does not impact the amount of cash distributions paid by us or the total number of outstanding units.
Distributions to our Unitholders
The following table details the distributions declared and/or paid for the periods presented:
 
Date Paid or to be Paid
Three Months Ended
 
Public Common
 
SPLC Common
 
SPLC Subordinated
 
General Partner
 
 
 
Distributions per Limited Partner Unit
 
IDR’s
 
2%
 
Total
 
 
 
 
(in millions, except per unit amounts)
February 12, 2015
December 31, 2014 (1)
 
$
4.8

 
$
2.2

 
$
7.1

 
$

 
$
0.3

 
$
14.4

 
$
0.10420

May 14, 2015
March 31, 2015
 
8.0

 
3.8

 
11.8

 

 
0.5

 
24.1

 
0.17500

August 13, 2015
June 30, 2015
 
10.2

 
4.1

 
12.8

 
0.1

 
0.5

 
27.7

 
0.19000

November 12, 2015
September 30, 2015
 
11.0

 
4.4

 
13.9

 
0.4

 
0.6

 
30.3

 
0.20500

February 11, 2016
December 31, 2015
 
13.9

 
4.7

 
14.8

 
1.2

 
0.7

 
35.3

 
0.22000

May 12, 2016
March 21, 2016
 
17.9

 
5.1

 
15.8

 
2.0

 
0.9

 
41.7

 
0.23500

August 12, 2016
June 30, 2016
 
22.0

 
5.4

 
16.9

 
3.7

 
1.0

 
49.0

 
0.25000

November 14, 2016
September 30, 2016
 
23.3

 
5.7

 
17.8

 
6.0

 
1.1

 
53.9

 
0.26375

February 14, 2017
December 31, 2016
 
24.5

 
5.9

 
18.7

 
8.3

 
1.2

 
58.6

 
0.27700

May 12, 2017
March 31, 2017
 
25.7

 
25.9

 

 
10.7

 
1.3

 
63.6

 
0.29100

August 14, 2017
June 30, 2017
 
26.9

 
27.0

 

 
12.9

 
1.4

 
68.2

 
0.30410

November 14, 2017
September 30, 2017
 
31.4

 
28.3

 

 
16.2

 
1.5

 
77.4

 
0.31800

February 14, 2018
December 31, 2017 (2)
 
32.9

 
29.6

 

 
18.9

 
1.7

 
83.1

 
0.33300


(1)     The fourth quarter 2014 minimum quarterly distribution was prorated for the 59-day period from November 3, 2014 to December 31, 2014 in accordance with the Partnership Agreement.
(2) For more information see Note 14 - Subsequent Events.
Distributions to Noncontrolling Interest
Distributions to SPLC for its noncontrolling interest in Zydeco were $8.9 million, $20.3 million and $67.1 million in 2017, 2016 and 2015, respectively. Distributions to GEL for its noncontrolling interest in Odyssey were $10.0 million, $9.9 million and $6.1 million in 2017, 2016 and 2015, respectively. See Note 4—Related Party Transactions for additional details.